Updating results

50 results for LUTS

Sort: Relevance | Date

Lower urinary tract symptoms in men: management (CG97)

This guideline covers managing lower urinary tract symptoms (LUTS) in men over 18. It aims to improve the quality of life for men with LUTS by recommending which assessments they should receive, and when conservative management, drug treatment and surgery can help.

Clinical guideline Published May 2010 Last updated June 2015

Lower urinary tract symptoms in men

Everything NICE has said on managing lower urinary tract symptoms in men in an interactive flowchart

NICE Pathway Published October 2012 Last updated January 2019

Lower urinary tract symptoms

All NICE products on lower urinary tract symptoms. Includes any guidance, advice, NICE Pathways and quality standards.

Topic page

Lower urinary tract symptoms secondary to benign prostatic hyperplasia: tadalafil (ESNM18)

Summary of the evidence on tadalafil for lower urinary tract symptoms secondary to benign prostate hyperplasia..

Evidence summary Published May 2013 Last updated October 2013

Improving the quality of care for men with lower urinary tract symptoms: shared decision making

with lower urinary tract symptoms (LUTS). Clinical peer review was focused on evidence of implementation of NICE guidance...

QP Case Study Published July 2016

Transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG629)

Evidence-based recommendations on transurethral water jet ablation for lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH)

Interventional procedures guidance Published September 2018

Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG625)

Evidence-based recommendations on transurethral water vapour ablation for lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH)

Interventional procedures guidance Published August 2018

Transurethral electrovaporisation of the prostate (IPG14)

Evidence-based recommendations on transurethral electrovaporisation of the prostate (TURP) to treat benign prostatic obstruction (BPO)

Interventional procedures guidance Published October 2003

Holmium laser prostatectomy (IPG17)

Evidence-based recommendations on holmium laser prostatectomy (removal of the prostate) for treating Benign prostatic obstruction (BPO)

Interventional procedures guidance Published November 2003

Rezum for treating benign prostatic hyperplasia (MIB158)

Advice on the use of Rezum (NxThera Inc) for treating benign prostatic hyperplasia (BPH) to aid local decision-making

Medtech innovation briefing Published August 2018

Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG641)

Evidence-based recommendations on prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia

Interventional procedures guidance Published January 2019

Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG611)

Evidence-based recommendations on prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia in adults

Interventional procedures guidance Published April 2018

UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG26)

Evidence-based recommendations on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (BHP)

Medical technologies guidance Published September 2015

Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia (IPG475)

Evidence-based recommendations on prostatic urethral lift implants to treat lower tract symptoms secondary to benign prostate hyperplasia (enlarged prostate)

Interventional procedures guidance Published January 2014

GreenLight XPS for treating benign prostatic hyperplasia (MTG29)

Evidence-based recommendations on GreenLight XPS for treating benign prostatic hyperplasia (BPH)

Medical technologies guidance Published June 2016

Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal) (TA273)

NICE is unable to make a recommendation about the use in the NHS of tadalafil for treating symptoms associated with benign prostatic hyperplasia...

Technology appraisal guidance Published January 2013

Urinary incontinence in neurological disease: assessment and management (CG148)

This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease. It aims to improve care by recommending specific treatments based on what symptoms and neurological conditions people have.

Clinical guideline Published August 2012

Sacral nerve stimulation for urge incontinence and urgency-frequency (IPG64)

Evidence-based recommendations on sacral nerve stimulation for treating overactive bladder (urge incontinence and urgency-frequency)

Interventional procedures guidance Published June 2004

Rezum for treating benign prostatic hyperplasia

In development [GID-MT529] Expected publication date: 06 April 2020

Medical technologies guidance In development

ADXBLADDER for detecting bladder cancer (MIB180)

Advice on ADXBLADDER for detecting bladder cancer to aid local decision making

Medtech innovation briefing Published April 2019

Urogenital conditions

Everything NICE has said on urogenital conditions in an interactive flowchart

NICE Pathway Published June 2015 Last updated November 2019

The TURis system for transurethral resection of the prostate (MTG23)

Evidence-based recommendations on the transurethral resection in saline system (TURis) for resection of the prostate

Medical technologies guidance Published February 2015

Prostatitis – antimicrobial prescribing

Everything NICE has said on antimicrobial prescribing for acute prostatitis in an interactive flowchart.

NICE Pathway Published October 2018 Last updated September 2019

Prostatitis (acute): antimicrobial prescribing (NG110)

This guideline sets out an antimicrobial prescribing strategy for acute prostatitis. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published October 2018

Medicines and technologies programme: adoption team

NICE Medicines and technologies programme: adoption team

Published September 2019 Last updated September 2019

Mirabegron for treating symptoms of overactive bladder (TA290)

Evidence-based recommendations on mirabegron (Betmiga) for treating the symptoms of overactive bladder

Technology appraisal guidance Published June 2013

Infracoccygeal sacropexy using mesh to repair uterine prolapse (IPG582)

Evidence-based recommendations on infracoccygeal sacropexy using mesh to repair uterine (womb) prolapse in women

Interventional procedures guidance Published June 2017

Shared learning awards previous winners and finalists

procedure, an ambulatory pathway for patients suffering from Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia New IV Fluids:...

Published June 2019 Last updated June 2019

BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume (MIB50)

Advice on the BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume to aid local decision-making

Medtech innovation briefing Published January 2016

Urethrotech UCD for difficult or failed catheterisation (MIB116)

Advice on the use of Urethrotech urethral catheterisation device (UCD) for difficult or failed catheterisations in men to aid local decision-making

Medtech innovation briefing Published August 2017

Memokath-028, 044 and 045 stents for urethral obstruction (MIB123)

Advice on the use of Memokath-028, 044 and 045 stents for urethral obstruction and bladder neck or outlet obstructions in men to aid local decision-making

Medtech innovation briefing Published October 2017

Urinary tract infections in adults (QS90)

This quality standard covers diagnosing and managing urinary tract infection in adults (aged 16 and over), including adults using urinary catheters. It includes assessment, antibiotic treatment and referral for specialist assessment. It describes high-quality care in priority areas for improvement.

Quality standard Published June 2015

Shared decision making (KTT23)

Improving the quality of care for men with lower urinary tract symptoms: shared decision making

Key therapeutic topic Published March 2019 Last updated September 2019

Prostate cancer (QS91)

This quality standard covers managing prostate cancer in people referred to secondary care or having follow-up for prostate cancer in primary care. It describes high-quality care in priority areas for improvement.

Quality standard Published June 2015 Last updated May 2019

Multiple sclerosis (QS108)

This quality standard covers diagnosing and managing multiple sclerosis (MS) in adults. It includes care, support and review for people with MS. It describes high-quality care in priority areas for improvement.

Quality standard Published January 2016

Axonics sacral neuromodulation system for overactive bladder and faecal incontinence (MIB164)

Advice on the use of Axonics sacral neuromodulation system (SNM) for overactive bladder and faecal incontinence to aid local decision-making

Medtech innovation briefing Published December 2018

Suspected cancer: recognition and referral (NG12)

This guideline covers identifying children, young people and adults with symptoms that could be caused by cancer. It outlines appropriate investigations in primary care, and selection of people to refer for a specialist opinion. It aims to help people understand what to expect if they have symptoms that may suggest cancer.

NICE guideline Published June 2015 Last updated July 2017

Urinary incontinence and pelvic organ prolapse in women

Everything NICE has said about managing urinary incontinence and pelvic organ prolapse in women in an interactive flowchart

NICE Pathway Published September 2013 Last updated July 2019

S-Cath System for suprapubic catheterisation (MIB68)

Advice on the use of the S-Cath System for suprapubic catheterisation to aid local decision-making

Medtech innovation briefing Published June 2016

Nocturia and nocturnal polyuria in men with lower urinary tract symptoms: oral desmopressin (ESUOM10)

This evidence summary has been withdrawn because a product containing oral desmopressin with a marketing authorisation for treating nocturia and nocturnal polyuria in men with lower urinary tract symptom is now available in the UK.

Evidence summary Published April 2013

Research recommendations

encourages further research into transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic...

Published April 2016 Last updated April 2016

Quality standard highlights need for greater awareness of men presenting with LUTS

NICE?s quality standard lower urinary tract symptoms (LUTS) highlights the need for greater awareness of the initial assessment and management of the condition.

News Published September 2013 Last updated September 2013